176 related articles for article (PubMed ID: 32494001)
1. Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques.
Lee MR; Shnitko TA; Blue SW; Kaucher AV; Winchell AJ; Erikson DW; Grant KA; Leggio L
Nat Commun; 2020 Jun; 11(1):2783. PubMed ID: 32494001
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay.
Lee MR; Scheidweiler KB; Diao XX; Akhlaghi F; Cummins A; Huestis MA; Leggio L; Averbeck BB
Mol Psychiatry; 2018 Jan; 23(1):115-122. PubMed ID: 28289281
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques.
Modi ME; Connor-Stroud F; Landgraf R; Young LJ; Parr LA
Psychoneuroendocrinology; 2014 Jul; 45():49-57. PubMed ID: 24845176
[TBL] [Abstract][Full Text] [Related]
4. Plasma and CSF oxytocin levels after intranasal and intravenous oxytocin in awake macaques.
Freeman SM; Samineni S; Allen PC; Stockinger D; Bales KL; Hwa GG; Roberts JA
Psychoneuroendocrinology; 2016 Apr; 66():185-94. PubMed ID: 26826355
[TBL] [Abstract][Full Text] [Related]
5. Intranasal oxytocin in rhesus monkeys alters brain networks that detect social salience and reward.
Parr LA; Mitchell T; Hecht E
Am J Primatol; 2018 Oct; 80(10):e22915. PubMed ID: 30295946
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury.
Meidahl AC; Eisenried A; Klukinov M; Cao L; Tzabazis AZ; Yeomans DC
Headache; 2018 Apr; 58(4):545-558. PubMed ID: 29266199
[TBL] [Abstract][Full Text] [Related]
7. Intranasal oxytocin selectively attenuates rhesus monkeys' attention to negative facial expressions.
Parr LA; Modi M; Siebert E; Young LJ
Psychoneuroendocrinology; 2013 Sep; 38(9):1748-56. PubMed ID: 23490074
[TBL] [Abstract][Full Text] [Related]
8. Intranasal oxytocin selectively modulates the behavior of rhesus monkeys in an expression matching task.
Taubert J; Flessert M; Liu N; Ungerleider LG
Sci Rep; 2019 Oct; 9(1):15187. PubMed ID: 31645593
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin.
Oppong-Damoah A; Zaman RU; D'Souza MJ; Murnane KS
Horm Behav; 2019 Feb; 108():20-29. PubMed ID: 30593782
[TBL] [Abstract][Full Text] [Related]
10. Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations.
Yeomans DC; Hanson LR; Carson DS; Tunstall BJ; Lee MR; Tzabazis AZ; Jacobs D; Frey WH
Transl Psychiatry; 2021 Jul; 11(1):388. PubMed ID: 34247185
[TBL] [Abstract][Full Text] [Related]
11. CSF and blood oxytocin concentration changes following intranasal delivery in macaque.
Dal Monte O; Noble PL; Turchi J; Cummins A; Averbeck BB
PLoS One; 2014; 9(8):e103677. PubMed ID: 25133536
[TBL] [Abstract][Full Text] [Related]
12. Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research.
Quintana DS; Lischke A; Grace S; Scheele D; Ma Y; Becker B
Mol Psychiatry; 2021 Jan; 26(1):80-91. PubMed ID: 32807845
[TBL] [Abstract][Full Text] [Related]
13. Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study.
Quintana DS; Westlye LT; Alnæs D; Kaufmann T; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
Neuropsychopharmacology; 2019 Jan; 44(2):306-313. PubMed ID: 30323359
[TBL] [Abstract][Full Text] [Related]
14. Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives.
Quintana DS; Smerud KT; Andreassen OA; Djupesland PG
Ther Deliv; 2018 Jul; 9(7):515-525. PubMed ID: 29943688
[TBL] [Abstract][Full Text] [Related]
15. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
[TBL] [Abstract][Full Text] [Related]
16. Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans.
Martins DA; Mazibuko N; Zelaya F; Vasilakopoulou S; Loveridge J; Oates A; Maltezos S; Mehta M; Wastling S; Howard M; McAlonan G; Murphy D; Williams SCR; Fotopoulou A; Schuschnig U; Paloyelis Y
Nat Commun; 2020 Mar; 11(1):1160. PubMed ID: 32127545
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates.
Galbusera A; De Felice A; Girardi S; Bassetto G; Maschietto M; Nishimori K; Chini B; Papaleo F; Vassanelli S; Gozzi A
Neuropsychopharmacology; 2017 Jun; 42(7):1420-1434. PubMed ID: 27995932
[TBL] [Abstract][Full Text] [Related]
18. Direct transport of VEGF from the nasal cavity to brain.
Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
[TBL] [Abstract][Full Text] [Related]
19. Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial.
Quintana DS; Westlye LT; Alnæs D; Rustan ØG; Kaufmann T; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
Psychoneuroendocrinology; 2016 Jul; 69():180-8. PubMed ID: 27107209
[TBL] [Abstract][Full Text] [Related]
20. Chronic and acute intranasal oxytocin produce divergent social effects in mice.
Huang H; Michetti C; Busnelli M; Managò F; Sannino S; Scheggia D; Giancardo L; Sona D; Murino V; Chini B; Scattoni ML; Papaleo F
Neuropsychopharmacology; 2014 Apr; 39(5):1102-14. PubMed ID: 24190025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
